Meet Our Team At The ASGCT 26th Annual Meeting; May 16-20, 2023| ASC

Join our team of experts at the 2023 ASGCT Annual Meeting. As a leading gene and cell therapy CRO/CDMO, we seek to support gene-editing and stem cell innovation for biomedical research and product development. We look forward to discussing your projects and how ASC can help support your research.

Event Details:
Booth #: 724
Dates:   May 16-20, 2023
Venue: Los Angeles Convention Center, Los Angeles, CA
Conference URL:  https://annualmeeting.asgct.org/

About Applied StemCell, Inc.

ASC has a Drug Manufacturing License from the California Department of Public Health, Food and Drug Branch (FDB). It has a Quality Management System (ISO 13485 certified) and established cGMP-compliant protocols for cell banking and manufacturing, iPSC generation, genome editing, iPSC differentiation, and cell product manufacturing. With over 13 years of gene-editing and stem cell expertise, ASC offers comprehensive and customized cell and gene CRO/CDMO solutions. Its core iPSC and genome editing (CRISPR and TARGATT^TM) technologies, facilitate site-specific, large cargo (up to 20kb) transgene integration and the development of allogenic cell products.

Media Contact:
Maki Ogawa
Marketing Director, Applied StemCell, Inc.
408-773-8007
maki.ogawa@appliedstemcell.com